Article abstract
Nature Medicine 14, 1067 - 1076 (2008)
Published online: 5 October 2008 | doi:10.1038/nm.1873
The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis
Przemyslaw Sapieha1,2,10, Mirna Sirinyan1,2,10, David Hamel1, Karine Zaniolo1, Jean-Sébastien Joyal1,2, Jang-Hyeon Cho3, Jean-Claude Honoré1, Elsa Kermorvant-Duchemin4, Daya R Varma2, Sophie Tremblay1, Martin Leduc1, Lenka Rihakova1, Pierre Hardy1, William H Klein3, Xiuqian Mu3, Orval Mamer5, Pierre Lachapelle6, Adriana Di Polo7, Christian Beauséjour1, Gregor Andelfinger1, Grant Mitchell1, Florian Sennlaub4,8,9 & Sylvain Chemtob1
Abstract
Vascularization is essential for tissue development and in restoration of tissue integrity after an ischemic injury. In studies of vascularization, the focus has largely been placed on vascular endothelial growth factor (VEGF), yet other factors may also orchestrate this process. Here we show that succinate accumulates in the hypoxic retina of rodents and, via its cognate receptor G protein–coupled receptor-91 (GPR91), is a potent mediator of vessel growth in the settings of both normal retinal development and proliferative ischemic retinopathy. The effects of GPR91 are mediated by retinal ganglion neurons (RGCs), which, in response to increased succinate levels, regulate the production of numerous angiogenic factors including VEGF. Accordingly, succinate did not have proangiogenic effects in RGC-deficient rats. Our observations show a pathway of metabolite signaling where succinate, acting through GPR91, governs retinal angiogenesis and show the propensity of RGCs to act as sensors of ischemic stress. These findings provide a new therapeutic target for modulating revascularization.
- Research Center of Centre Hospitalier Universitaire Sainte-Justine, Departments of Pediatrics and Pharmacology, Université de Montréal, Montreal, Quebec H3T 1C5, Canada.
- Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
- Department of Biochemistry and Molecular Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
- Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche Scientique S 872, Centre de Recherche des Cordeliers, F-75006 Paris, France.
- Mass Spectrometry Facility, Department of Medicine, McGill University Montreal, Quebec H3A 1A4, Canada.
- Departments of Ophthalmology and Neurology-Neurosurgery, McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec H3H 1P3, Canada.
- Department of Pathology and Cell Biology, University of Montreal, Montreal, Quebec H3T 1J4, Canada.
- Université Pierre et Marie Curie (Paris 6), Unité Mixte de Recherche Scientique S 872, F-75006 Paris, France.
- Université Paris Descartes, Unité Mixte de Recherche Scientique 872, F-75006 Paris, France.
- These authors contributed equally to this work.
Correspondence to: Sylvain Chemtob1 e-mail: sylvain.chemtob@umontreal.ca
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
A radically twisted lipid regulates vascular deathNature Medicine News and Views (01 Dec 2005)
RESEARCH
Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularizationGene Therapy Original Article
Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularizationLaboratory Investigation Research Article
HLF/HIF-2α is a key factor in retinopathy of prematurity in association with erythropoietinThe EMBO Journal Article (03 Mar 2003)
See all 50 matches for Research
